PTEN Deletion and Heme Oxygenase-1 Overexpression Are Associated with Adverse Clinical Outcome and Cooperate in Prostate Cancer Progression

被引：0
|
作者：
Li, Y.
Jack, S.
DingZhang, X.
Yoshimoto, M.
Liu, S.
Bijian, K.
Gupta, A.
Squire, J. A.
Zhang, J.
Jamali, M. Alaoui
Bismar, T. A.
机构：
[1] Univ Calgary, Calgary, AB T2N 1N4, Canada
[2] Calgary Lab Serv, Calgary, AB, Canada
[3] McGill Univ, Montreal, PQ, Canada
[4] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangzhou, Guangdong, Peoples R China
[5] Queens Univ, Kingston, ON, Canada
来源：
MODERN PATHOLOGY | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
875
引用
收藏
页码：207A / 207A
页数：1
相关论文
共 50 条
  • [21] A novel selective heme oxygenase-1 targeted therapy for androgen-refractory prostate cancer
    Alaoui-Jamali, Moulay
    Bismar, Tarek
    Gupta, Ajay
    Szarek, Walter A.
    Schipper, Hyman
    CANCER RESEARCH, 2009, 69
  • [22] THE ROLE OF HEME OXYGENASE-1 AND CARBON MONOXIDE (CO) IN REGULATION OF CHEMOTHERAPEUTIC RESPONSES IN PROSTATE CANCER
    Wegiel, B.
    Sachs, A.
    Persson, J.
    Bjartell, A.
    Otterbein, L. E.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 342 - 342
  • [23] Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas
    Gandini, Norberto A.
    Fermento, Maria E.
    Salomon, Debora G.
    Blasco, Jorge
    Patel, Vyomesh
    Gutkind, J. Silvio
    Molinolo, Alfredo A.
    Facchinetti, Maria M.
    Curino, Alejandro C.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2012, 93 (02) : 237 - 245
  • [24] Dynamics of antioxidant heme oxygenase-1 and pro-oxidant p66Shc in promoting advanced prostate cancer progression
    Miller, Dannah R.
    Ingersoll, Matthew A.
    Chou, Yu -Wei
    Kosmacek, Elizabeth A.
    Oberley-Deegan, Rebecca E.
    Lin, Ming-Fong
    FREE RADICAL BIOLOGY AND MEDICINE, 2022, 193 : 274 - 291
  • [25] Is PTEN loss associated with clinical outcome measures in human prostate cancer?
    McCall, P.
    Witton, C. J.
    Grimsley, S.
    Nielsen, K. V.
    Edwards, J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (08) : 1296 - 1301
  • [26] Is PTEN loss associated with clinical outcome measures in human prostate cancer?
    P McCall
    C J Witton
    S Grimsley
    K V Nielsen
    J Edwards
    British Journal of Cancer, 2008, 99 : 1296 - 1301
  • [27] DKC1 overexpression associated with prostate cancer progression
    Sieron, P.
    Hader, C.
    Hatina, J.
    Engers, R.
    Wlazlinski, A.
    Mueller, M.
    Schulz, W. A.
    BRITISH JOURNAL OF CANCER, 2009, 101 (08) : 1410 - 1416
  • [28] DKC1 overexpression associated with prostate cancer progression
    P Sieron
    C Hader
    J Hatina
    R Engers
    A Wlazlinski
    M Müller
    W A Schulz
    British Journal of Cancer, 2009, 101 : 1410 - 1416
  • [29] Donor heme oxygenase-1 length polymorphism is not associated with outcome after human liver transplantation.
    Buis, CI
    Geuken, E
    Visser, DS
    Hepkema, GSVDB
    Leuvenink, HGD
    Slooff, MJH
    Porte, RJ
    LIVER TRANSPLANTATION, 2005, 11 (07) : C6 - C6
  • [30] Erratum: Deciphering the Nuclear Role of Heme Oxygenase-1 in Prostate Cancer: Transcriptional Reprogramming and Neuroendocrine Differentiation
    Gueron, Geraldine
    JCO GLOBAL ONCOLOGY, 2024, 10
12345